Clinical Trial

PrEPsmart 2-1-1 Pilot

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated October 8, 2024 (before its estimated January 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a pilot study to assess the feasibility, acceptability, and preliminary effectiveness of pre-exposure prophylaxis (PrEP)smart among cisgender sexual minority males (SMM) taking on-demand PrEP over a 6-month period. Upon project completion, the investigators will have developed a highly innovative tool to support men who have sex with men (MSM) using on-demand PrEP ready for testing in a larger efficacy trial
Trial Details
NCT Number NCT06631365
Lead Sponsor Public Health Foundation Enterprises, Inc.
Collaborators: Gilead Sciences
Conditions HIV-1-infection
Enrollment 60 participants
Start Date 2023-10-02
Primary Completion 2025-01-01 (estimated)
Study Completion 2025-04-01 (estimated)
Updated on ClinicalTrials.gov 2024-10-08